| Pharmaceutical active ingredients: |
| Paclitaxel |
| Available forms, composition and doses of Lipopac: |
| N / A |
| Lipopac medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01CD01 - Paclitaxel |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Lipo-Levazine | Sulfadiazine | Unidentified Pharmaceutical Company |
| Lipolutin | Progesterone | Unidentified Pharmaceutical Company |
| Lipo-Lutin | Progesterone | Unidentified Pharmaceutical Company |
| Lipomid | Clofibrate | Unidentified Pharmaceutical Company |
| Liponox NCY | Nonoxynol 9 | Unidentified Pharmaceutical Company |
| Liporeduct | Clofibrate | Unidentified Pharmaceutical Company |
| Liporil | Clofibrate | Unidentified Pharmaceutical Company |
| Liposid | Clofibrate | Unidentified Pharmaceutical Company |
| Liposorb | Polysorbate 20 | Unidentified Pharmaceutical Company |
| Liprin | Clofibrate | Unidentified Pharmaceutical Company |